» Articles » PMID: 33664417

Caffeine Promotes Angiogenesis Through Modulating Endothelial Mitochondrial Dynamics

Overview
Specialty Pharmacology
Date 2021 Mar 5
PMID 33664417
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Caffeine induces multiple vascular effects. In this study we investigated the angiogenic effect of physiological concentrations of caffeine with focus on endothelial cell behaviors (migration and proliferation) during angiogenesis and its mitochondrial and bioenergetic mechanisms. We showed that caffeine (10-50 μM) significantly enhanced angiogenesis in vitro, evidenced by concentration-dependent increases in tube formation, and migration of human umbilical vein endothelial cells (HUVECs) without affecting cell proliferation. Caffeine (50 μM) enhanced endothelial migration via activation of cAMP/PKA/AMPK signaling pathway, which was mimicked by cAMP analog 8-Br-cAMP, and blocked by PKA inhibitor H89, adenylate cyclase inhibitor SQ22536 or AMPK inhibitor compound C. Furthermore, caffeine (50 μM) induced significant mitochondrial shortening through the increased phosphorylation of mitochondrial fission protein dynamin-related protein 1 (Drp1) in HUVECs, which increased its activity to regulate mitochondrial fission. Pharmacological blockade of Drp1 by Mdivi-1 (10 μM) or disturbance of mitochondrial fission by Drp1 silencing markedly suppressed caffeine-induced lamellipodia formation and endothelial cell migration. Moreover, we showed that caffeine-induced mitochondrial fission led to accumulation of more mitochondria in lamellipodia regions and augmentation of mitochondrial energetics, both of which were necessary for cell migration. In a mouse model of hindlimb ischemia, administration of caffeine (0.05% in 200 mL drinking water daily, for 14 days) significantly promoted angiogenesis and perfusion as well as activation of endothelial AMPK signaling in the ischemic hindlimb. Taken together, caffeine induces mitochondrial fission through cAMP/PKA/AMPK signaling pathway. Mitochondrial fission is an integral process in caffeine-induced endothelial cell migration by altering mitochondrial distribution and energetics.

Citing Articles

Caffeine as an Active Molecule in Cosmetic Products for Hair Loss: Its Mechanisms of Action in the Context of Hair Physiology and Pathology.

Szendzielorz E, Spiewak R Molecules. 2025; 30(1.

PMID: 39795223 PMC: 11720832. DOI: 10.3390/molecules30010167.


Caffeine improves mitochondrial dysfunction in the white matter of neonatal rats with hypoxia-ischemia through deacetylation: a proteomic analysis of lysine acetylation.

Zhang Y, Wang Y, Dou H, Wang S, Qu D, Peng X Front Mol Neurosci. 2024; 17:1394886.

PMID: 38745725 PMC: 11091324. DOI: 10.3389/fnmol.2024.1394886.


Decreasing mitochondrial fission ameliorates HIF-1α-dependent pathological retinal angiogenesis.

Huang S, Cao K, Wang C, Chen P, Chen Y, Zhang Y Acta Pharmacol Sin. 2024; 45(7):1438-1450.

PMID: 38565961 PMC: 11192750. DOI: 10.1038/s41401-024-01262-3.


Mitochondrial Dysfunction in Endothelial Progenitor Cells: Unraveling Insights from Vascular Endothelial Cells.

Kulovic-Sissawo A, Tocantins C, Diniz M, Weiss E, Steiner A, Tokic S Biology (Basel). 2024; 13(2).

PMID: 38392289 PMC: 10886154. DOI: 10.3390/biology13020070.


Vitamin B12 Supplementation Improves Oocyte Development by Modulating Mitochondria and Yolk Protein in a Caffeine-Ingested Model.

Min H, Lee M, Kang S, Shim Y Antioxidants (Basel). 2024; 13(1).

PMID: 38247478 PMC: 10812423. DOI: 10.3390/antiox13010053.


References
1.
Bian X, Ma K, Zhang C, Fu X . Therapeutic angiogenesis using stem cell-derived extracellular vesicles: an emerging approach for treatment of ischemic diseases. Stem Cell Res Ther. 2019; 10(1):158. PMC: 6545721. DOI: 10.1186/s13287-019-1276-z. View

2.
Conway E, Collen D, Carmeliet P . Molecular mechanisms of blood vessel growth. Cardiovasc Res. 2001; 49(3):507-21. DOI: 10.1016/s0008-6363(00)00281-9. View

3.
Losordo D, Dimmeler S . Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation. 2004; 109(22):2692-7. DOI: 10.1161/01.CIR.0000128596.49339.05. View

4.
Losordo D, Dimmeler S . Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation. 2004; 109(21):2487-91. DOI: 10.1161/01.CIR.0000128595.79378.FA. View

5.
Herbert S, Stainier D . Molecular control of endothelial cell behaviour during blood vessel morphogenesis. Nat Rev Mol Cell Biol. 2011; 12(9):551-64. PMC: 3319719. DOI: 10.1038/nrm3176. View